ABSTRACT
INTRODUCTION
Caffeine (Caf) is a central nervous stimulant and a common constituent of supplements and energy-drinks based on the premise of improved physical performance with associated short term side effects including headache, nausea, and tremors with mild consumption. However, long term caffeine use is not well understood. The National Collegiate Athletic Association (31) mandates urinary levels > 15 µg/ml as illegal for competing athletes. This equates to 13 mg/kg or roughly 8 cups of coffee (12, 17) . Current literature has documented caffeine as an ergogenic aid in endurance exercise (For reviews see; Goldstein (14) and Magkos (29) . However, a review by Davis (9) indicates that research investigating caffeine's impact on anaerobic
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International Journal of Exercise Science http://www.intjexersci.com 244 performance has produced equivocal results, potentially attributable to testing of untrained individuals and habitual vs. nonhabitual caffeine users, diverse modes of testing (wingates vs. traditional weight lifting), muscle mass tested, and administration of varying caffeine dosages (2-10mg/kg).
Lower body Wingate anaerobic tests (Want) are an accepted model to assess anaerobic capacity (23) . However, the efficacy of caffeine on Want performance remains unclear. Greer (20) and Williams et al. (37) found caffeine (6-7 mg/kg of body mass) resulted in no change in repeated (20) or single effort (37) Wingates ranging from 15-30 s. However, the authors attributed results to the untrained status of participants. Woolf et al (39) found caffeine (5 mg/kg) significantly increased total weight (reps x resistance) lifted for bench press and peak power for Wingate for highly fit males. However, total weight lifted for leg press only approached significance (p = 0.09). Anselm et al. (2) showed ingestion of 250 mg of caffeine prior to exercise increased peak anaerobic power in anaerobically untrained participants during a 6 s Want. Additionally, Kang et al. (26) found caffeine ingestion of both 2.5 and 5 mg/kg improved Want performance in untrained individuals. Conversely, Greer et al. (19) showed caffeine (6 mg/kg) had no ergogenic effect during repeated (4 x 30 s) Want with some evidence caffeine hindered performance in later bouts.
Bugyi et al. (6) showed no significant difference in hand grip (HG) strength after caffeine ingestion of 167, 324, and 500 mg. However, caffeine dosage was not based on participant's body mass and some participants likely failed to reach critical levels of caffeine ingestion (i.e. > 3-9 mg/kg of body mass) previously shown to elicit an increase in performance (17, 9). Further, with HG testing, the lack of mode specific trained participants could mitigate potential ergogenic properties of caffeine. Bellar et al. (5) Caffeine's ergogenic properties were originally theorized due to enhanced free fatty acid mobilization consequent to glycogen sparing, however this provides minimal impetus for enhanced performance (with acute caffeine supplementation) during exercise dominated by oxygenindependent metabolic pathways justifying further investigation. However, caffeine has been shown to have analgesic properties and a consistent blunting of perceptual pain responses in steady state exercise (27) . Far less investigation into caffeine's analgesic properties in repeated high intensity efforts has occurred. Caffeine buffers pain (vs. placebo), evidenced by perceptual and pain responses being blunted when similar work is completed or unaltered when greater work is performed (3, 18, 22, 34) . Additionally, reduction in perceived levels of pain may be dose dependent per individual (32).While analgesic potential of caffeine offers a reasonable mechanism, discrepancies among previous studies International Journal of Exercise Science http://www.intjexersci.com 245 make further research warranted to clarify caffeine's effect on anaerobic performance. Additionally, there appears to be a dose response effect with caffeine to potentially observe ergogenic benefits (3-7mg/kg). Therefore, this study examined effects of caffeine ingestion at 7mg/kg on repeated upper and lower body Want and hand grip performance in anaerobically trained males.
METHODS

Participants
Participants were males (ages 19-45) who frequently engaged in high-intensity training (HIT) methods involving both upper and lower body exercises >3 days/week. Participants completed an informed consent form and were screened for apparent chronic disease risks using the PAR-Q (38) and a health questionnaire. Participants also completed questionnaires concerning daily caffeine use (33) and training history. Height (cm) and body mass (kg) were determined using a stadiometer (Detecto, Webb City, MO) and a calibrated digital scale (Tanita BWB-800, Tokyo, Japan). Body fat percentage was estimated using skinfold calipers (Lange, Cambridge, MD) and the three site method for males (chest, abdomen, thigh) (24). During each trial, peak heart rate was obtained using Team2 system heart rate monitors (Polar Electro Oy, Kempelee, Finland). Participants were instructed to report to the lab for testing well-hydrated, having avoided consumption of caffeine, alcohol, and any heavy physical exertion 24 h prior to all trials. Participants documented their dietary intake 24 h prior to the first session which served as a familiarization trial and were instructed to duplicate the diet for each trial.
Participants followed these instructions and replicated dietary intake for all subsequent trials. Descriptions of exercise testing are included below and were replicated for the familiarization session and both treatment sessions. All procedures were approved by the institutions internal review board (IRB) and in followed procedures in accordance with the ethical standards of the Helsinki Declaration. Participants ingested either caffeine (Caf) (7 mg/kg) or matched placebo (Pl) pills (lactose) in soft capsule form, 1 h prior to reporting to the laboratory. The primary investigator prepared paired sets of pills (Caf and Pl) in clear storage bags and received verbal confirmation of ingestion 1 hr prior to trial by the participant. Caf and Pl trials were completed in a counterbalanced order and in a doubleblind manner.
Statistical Analysis
Data was analyzed utilizing SPSS and an alpha of 0.05 was set a priori. A series of 2 (trial) x 6 (Wingate) repeated measures ANOVA's were used to compare dependent measures including performance (Ppeak, Pmean, Ftg%) and perceptual data (MMP, RPE, and PRS). A two-way repeated-measures ANOVA and Tukey's LSD post hoc test were used to examine differences in HR. Session RPE and Trial RPE were analyzed between Caf and Pl trials using paired samples T-test per exercise mode.
RESULTS
Descriptive data are shown in Table 1 . Trial means for performance are shown in Table  2 . Upper Body Wingate: A significant main effect for trial was observed for Ppeak ( No significant differences were found between trials for HG peak power (Caf: 52.7 + 1.7 kg vs. Pl: 53.0 + 1.3 kg), RPE, MPP, or PRS. HG HR (b/min) was found significantly higher (Caf: 130 + 15, vs. Pl: 122 + 16) and follow up tests showed significantly greater values for Caf for HR for all bouts No significant difference was found in HG S-RPE (Table 2) .
DISCUSSION
The major finding of the current study was 7 mg/kg of Caf resulted in a significant (18) found caffeine significantly increased reps to failure during leg press in the third (but not first two) of three sets, but in none of three sets for bench press. Hudson et al. (22) tested trained individuals on upper body (arm curls) and lower body (leg extensions) resistance exercise. Leg extension and arm curl reps to failure significantly improved (attributed to first two of four sets to failure). Current results were similar to Beck et al. (4) (35) found increased motor unit activity in rats via antagonism of adenosine receptors at doses of caffeine of 7.5 mg/kg. Assuming greater muscle volume contains a greater absolute volume of adenosine receptors, it is plausible that individuals with a higher overall volume of muscle mass may potentially respond more positively to caffeine supplementation, although direct evidence is lacking. Given the "trained" (vs. sedentary) status of current participants, the expectation for improved performance would be plausible based on the previous statement. However, various performance tasks may differ following acute caffeine supplementation based on muscle volume involved in testing which is often dictated by testing mode. The results of the current study potentially support the previously stated theory given the improved performance for upper body, similar to Beck et al. figure 1, 2, 3) . Though the results of the studies are contradictory regarding muscle body regions that experienced performance differences; all three studies utilized trained individuals and observed a positive effect from caffeine in at least one body region.
Greater absolute adenosine receptor volume would be anticipated with greater muscle volume. However, it is also reasonable that highly trained individuals may also be more likely to experience improvement if caffeine's ergogenic benefit is rooted in adenosine receptor antagonism. Because untrained muscle lacks neural adaptation (vs. trained muscle), a lower percentage and absolute number of total fibers may be activated during work. Consequently, there is less opportunity an ergogenic benefit to manifest through adenosine receptor antagonism. This theory has not been directly investigated yet could partially explain observations of improvement in trained and not in untrained participants. Further investigation is needed to clarify the potential role of muscle volume and training status with regard to caffeine, in particular, mechanistic factors.
Current results for LWant support Collomp et al. (7), Williams et al. (37) , and Greer et al. (19) that Caf had no effect on LWant performance. Williams et al. (37) observed caffeine having no effect on mean power in 15 s maximal effort cycling. Greer et al. (19) utilized a similar Caf does (6 mg/kg) and found peak and mean performance did not improve on the first 3 of 4 consecutive LWant but did increase on the final bout. However, it is important to note the participants in Greer et al (19) were unaccustomed to intense exercise. Plausibly no effect was observed because the utilization of untrained individuals prevented potential benefits from caffeine supplementation. Similarly, testing of nonhabitual users creates the potential for caffeine-induced nausea which may impair performance at 6 mg/kg of caffeine (21) . However the current study included trained individuals while finding a International Journal of Exercise Science http://www.intjexersci.com 250 significant difference between Pl vs. Caf Pmean LWant (Figure 4) . Additionally, RPE in the 6 th Want was significantly higher (p = 0.02, Caf: 7.6 + 0.8 vs. Pl: 6.9 + 1.0). Astorino et al. (3) found similar RPE and pain levels during leg extensions (2 sets of 40) Caf (5mg/kg) vs. Pl demonstrating a lack of pain blunting effect of caffeine on RPE similar to the current study. It is unclear why RPE was higher given the lack of differences in performance in the current study. LWant always followed UWant bouts and significantly greater performance was observed for Caf trials during UWant ( Figure  2 ). While remote, it is possible that, because LWant followed the upper body bouts, RPE was higher during Caf because of greater "pre" fatigue resulting from greater work volume during Caf UWant (Table 2) . Interesting to note, LWant PRS was significantly higher for Pl vs. Caf (5.68 + 1.9 vs. 5.00 + 2.2). Greater PRS demonstrated participant's subjective feelings of greater recovery and preparedness for ensuing bouts during Pl. This potentially supports the concept that lack of a significant difference for LWant may be attributed to residual fatigue from UWant. A negative reaction to high caffeine dosage can arguably be eliminated as no adverse reactions were observed or reported by participants.
Similar to Bugyi et al. (6) , the current study showed no significant difference in mean hand grip performance between Caf vs. Pl trials. However, unlike the current study, caffeine dosage was not based on participant's body mass in Bugyi et al. (6) . Basing dosage on participant body mass plausibly ensured that critical levels of caffeine to induce potential ergogenic effects were reached in those who would respond positively to caffeine administration. Our mode (repeated maximal static efforts) could negate any potential ergogenic response given the small volume of muscle utilized during hand grip testing. If a critical level of muscle volume is necessary to observe an ergogenic effect from caffeine, detection of improved performance would be difficult in the current (handgrip testing) paradigm. No analgesic effect of caffeine was observed in HG MPP (Table 2) in the current study contradicting Bellar et al. (5) who found pain perception was lowered by caffeine in hand grip to exhaustion Caf even when group means for time to exhaustion were higher Caf. However, the contradiction in perceptual ratings potentially could be attributed to mode of testing (15 s vs. time to exhaustion). Greater exercise duration (~100 s vs. a standardized 15 s) would have the potential to generate greater pain levels creating a situation in which caffeine, as an analgesic, might have greater potential to function. Lack of differences in HG MPP, with similar power, supports the notion that pain perception is influenced by volume of muscle performing work (i.e. relationship between muscle volume and volume of work performed influence on pain perception) and in this paradigm caffeine failed to influence MPP.
During high intensity exercise, caffeine has demonstrated analgesic properties and consistent blunting effect on perceptual responses (10, 30) . Although no difference was observed in power levels, RPE approached significance during Pl LWant (p = 0.11), failing to provide strong support for caffeine's hypoalgesic effects of a lower RPE at the same workload (Caf: 3.42 + 1.50 vs. Pl: 3.27 + 1.71). It is plausible that International Journal of Exercise Science http://www.intjexersci.com 251 caffeine buffers pain as similar or increased work is performed (caffeine vs. placebo trials); yet perceptual responses are blunted or unaltered respectively (3, 18, 22, 34) . Furthermore, current results show perceptual pain measures systematically increased with increased muscle volume utilized (Table 2) . Additionally, reduction in reported levels of pain may be dose dependent due to individual variability required to reach critical levels (32). Killen et al. (27) observed significantly lower Session-RPE for Caf vs. Pl (6.1 ± 2.2 vs. 6.8 ± 2.1) following 30 min of sub-max cycling equated for intensity and total work volume. In the current study, S-RPE was not significantly different for any exercise, nor was T-RPE significantly different for Caf. However, group means were higher for all 3 exercises Caf vs. Pl RPE ( Table 2 ). The contradictory results between studies may potentially be explained by mode of exercise (aerobic vs. anaerobic). As stated earlier, LWant PRS was significantly higher for Pl (vs. Caf), but no significant difference was observed for PRS in UWant or HG; however, group means were higher for all exercises during Pl (Table 2 ). This indicates the high caffeine dosage may have impacted some participants negatively given the subjective measures show participants anticipated performing better on the ensuing bout (when not on caffeine). Laurent et al. (28) demonstrated a correlation between expected performance using the PRS scale and actual performance for the ensuing exercise bout. In that study recovery (PRS) was estimated prior to an entire exercise bout following variable days of recovery. In the current study, PRS was taken repeatedly between bouts essentially reflecting participant's perceived readiness for the next bout. Results were inconclusive given participants performed better during the UWant Caf trial but PRS group means were higher during Pl; LWant Pmean was higher during Pl and correlated with a higher PRS, while HG max performance was not statistically different nor was PRS (though group mean was higher during Pl). PRS responses and performance in the current study was potentially disrupted by the acute caffeine supplementation and the way in which the PRS scaled was applied. The PRS scale was intended to assess recovery status prior to exercise in a global manner and has not been validated to function as a readiness scale between acute repeated bouts. Even so, it is conceivable that the subjective scale (PRS) lacked sensitivity to detect the small differences in performance in the current design. Further investigation is needed to determine how caffeine ingestion may alter perceptual feelings regarding recovery status.
Because there appears to be inter-individual variability regarding caffeine's' ergogenic potential, conclusions based solely on analysis of mean data may be misleading. It is therefore important to consider individual responses. In the current study 7/10 individuals consumed caffeine daily at rates > 1.8mg/kg. Of these 7 habitual users, 6 showed mean improvement following Caf (vs Pl) ingestion for Peak for UWant (0.61W/kg) and LWant 0.44 W/kg), while the single non-responder (Pl > Caf performance) possessed the highest BF % in the study and produced the lowest W/kg UWant, Pmean and LWant, Pmean in the current study (supporting earlier speculation based on Svenningsson et al. (35) improved bench press reps to failure. Similar to current results, Woolf's study emphasizes that it is imperative to examine 'responders vs. non-responders' (i.e. individual data) to provide an in-depth evaluation regarding effects of caffeine on anaerobic exercise. Similarly, Jordan et al. (25) examined acute caffeine supplementation at 6 mg/kg on repeated sprints (12 x 30 m) between caffeine naïve (<50 mg per day) and habitual (>300 mg per day) college age males and females. No significant differences were found between Caf consumers and non-consumers in performance. However fastest individual sprint time for all participants followed caffeine consumption. Additionally, mean sprint times for the caffeine trial were faster compared to mean sprint times for the placebo trial and mean RPE was higher during the caffeine trial compared to the placebo trial (13.9 + 1.5 vs. 13.3 + 1.6). While significant differences in sprint times were not identified based on common values used to restrict type I error rate, it is emphasized that seemingly minor differences in anaerobic athletic competitions can be of great practical importance.
More research is required to definitively determine the effect of caffeine on intense anaerobic exercise. One flaw of acute caffeine supplementation research is a clear consensus on what constitutes a habitual caffeine user.. Future studies should define habitual users using daily intake relative to body mass (mg/kg) rather than daily absolute caffeine ingestion. Caffeine should be administered during a multitude of activities in dosages at or above levels previously shown to enhance performance. The ability to mask caffeine supplementation is difficult, but 6 out of 10 participants incorrectly guessed which treatment they received first and was considered but a direct analysis was omitted. However, one constant that should remain is the utilization of anaerobically trained individuals. In Davis' (9) review, of 18 studies showing an ergogenic effect of caffeine, 15 utilized trained individuals, 2 untrained and 1 did not provide training background. Further investigations should focus on more practical approaches reflecting athletic competitions and training, utilizing a strength-to-weight ratio. It is also critical to assess individual responses rather than drawing conclusions based solely on analysis of aggregate data.
The current study demonstrated caffeine's ergogenic properties in certain paradigms (upper body wingates during early sets) and failure to influence performance in others (lower body wingates and static hand grips). Plausibly, caffeine's ergogenic properties may be limited to trained International Journal of Exercise Science http://www.intjexersci.com 253 individuals targeting appropriate muscle mass (mode and set dependent) following ingestion of a required critical dosage. Given a large dose of caffeine, acute negative side effects are plausible which could hinder performance. Additionally, research should not focus only on performance variables; instead continue to investigate perceptual responses to caffeine during exercise. Admittedly, one confounder of caffeine research is the dynamic variability in methodology making it problematic to compare findings to identify a definitive, global answer regarding caffeine's potential impact on exercise bouts dominated by anaerobic metabolic ATP production. Therefore research should continue to focus on the responder vs. non-responder concept in attempts to identify the parameters that create a responder to caffeine's ergogenic properties.
